4:35 am Natco Pharma and Orchid Chemicals and Pharmaceuticals have received an adverse observation report, commonly known as Form 483, after inspections conducted in their manufacturing units earlier this year by the US Food and Drug ... BioSpace, 1 week ago
Orchid Chemicals & Pharmaceuticals : NATCO, ORCHID GETS A STRONG DOSE OF US FDA MEDICINE - 4 Traders, 1 week ago
Natco Pharma, Orchid Chemicals get a strong dose of US FDA medicine - Financial Express, 2 weeks ago
1 images for "orchid chemicals and pharmaceuticals"
According to Mayuresh Joshi, VP- Institution at Angel Broking, one may exit Orchid Chemicals and Pharmaceuticals on rallies.Money Control, 1 month ago Exit Orchid Chemicals, says Kunal Saraogi Money Control, 1 month ago
Orchid Chemicals and Pharmaceuticals has suffered setback during the third quarter ended June 2014 and its net loss increased to Rs. 60.14 crore from Rs. 54.50 crore in the corresponding period of last year despite net sales growth of 12.1 per cent ...PharmaBiz, 1 month ago Orchid Chemicals & Pharmaceuticals reports net loss of Rs 60.14 crore in the June 2014 quarter Business Standard, 1 month ago Orchid Pharma registers turnover of Rs 285 crore in Q3 FY14 Noodls, 1 month ago
This page uses frames, but your browser doesn'tCapital Market, 1 month ago
Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014', provides an overview of the Orchid Chemicals & Pharmaceuticals ...Town Hall, 1 month ago New Market Research Report: Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014 Town Hall, 1 month ago New Report Available Orchid ChemicalsPharmaceuticals Ltd - Product Pipeline Review - 2014 MENAFN, 1 month ago Orchid Chemicals & Pharmaceuticals Ltd - Product Pipeline Review - 2014 Town Hall, 1 month ago
US-based injectable drugs major Hospira Inc has completed the acquisition of the Active Pharmaceutical Ingredient (API) manufacturing facility and associated research and development (R&D) facility from Chennai-based Orchid Chemicals and ...Business Standard, 2 months ago Orchid Chem hits 52-wk high, up 3%; seals deal with Hospira Money Control, 2 months ago Orchid completes Hospira deal, implementation of CDR package Business Standard, 2 months ago
Cipla, Sun Pharma, Lupin, Cadila Healthcare, Aurobindo and Glenmark are up 2-4%, quoting at their lifetime highs. Deepak Korgaonkar | Mumbai August 20, 2014 Last Updated at 13:27 IST Shares of pharmaceutical companies are on a roll with most of the ...Business Standard India, 1 month ago
Lucidio Studio, Inc./ In the first seven months of 2014, eight API manufacturers were issued warning letters by FDA due to infractions ranging from failure to maintain records; labeling and branding issues; failure to perform laboratory tests and ...PharmTech.com, 2 days ago API Developers Pass Inspections and Upgrade Capabilities PharmTech.com, 2 weeks ago
5:10pm IST (Adds foreign investor flows) * BSE index gains 0.77 pct; NSE ends 0.72 pct higher * Spain's CIE to take majority stake in Mahindra's auto parts unit * Larsen & Toubro vying for defence orders worth up to $1.4 bln By ...Reuters India, 5 days ago Indian shares gain for second day; Fed outlook, flows key Reuters India, 5 days ago
Thousands of researchers will descend on Boston this fall for an event billed as the world's largest gathering of synthetic biologists. The field is evolving so rapidly that even scientists working in it don't agree on a definition, but at its core ...Yahoo! Finance, 6 days ago
on your WebpageAdd Widget >Get your members hooked!